Conéctate
E-mail
Contraseña
Mostrar la contraseña
Recuerde
¿Olvidó su contraseña?
Inscríbase gratis
Regístrate
Regístrate
Configuraciones
Configuraciones
Cotizaciones dinámicas 
OFFON

MERCK & CO., INC.

(MRK)
ResumenCotizacionesGráficosNoticiasRatingsAgendaEmpresaFinanzasConsensoRevisionesDerivados 
ResumenTodasRecomendaciones analistasOtros idiomasComunicadosPubls. oficialesNoticias del sectorEstrategias MarketScreener
Noticias en otros idiomas sobre MERCK & CO., INC.
14/01Pfizer Reportedly Seeks Japan Approval for COVID-19 Pill
14/01Merck's COVID-19 Pill Molnupiravir Gets Emergency Approval in Indonesia
12/01I-Mab Doses First Phase 2 Clinical Trial of Efineptakin Alfa, Keyrtruda Combination in ..
12/01IMV Doses First Patient in Study for Lymphoma Treatment
11/01Aligos Therapeutics Shares Rise 6% on Merck Collaboration Agreement
11/01GLOBAL MARKETS LIVE : Airbus, Nokia, Pandora, Darktrace, Amazon...
11/01TODAY ON WALL STREET : All eyes on Powell
11/01Aligos Therapeutics, Merck Expand Collaboration in Nonalcoholic Steatohepatitis
11/01Merck's KEYTRUDA (pembrolizumab) Showed Statistically Significant Improvement in Diseas..
11/01Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy in Combi..
11/01Yumanity Therapeutics to Receive $5 Million Milestone Payment From Merck
11/01Aligos Therapeutics Expands Collaboration Deal With Merck
11/01Aligos Therapeutics, Inc. Expands Collaboration with Merck to Develop Oligonucleotide T..
11/01MERCK : nouveaux résultats encourageants pour Keytruda
11/01Le Nasdaq évite in extremis une bonne correction
11/01EN DIRECT DES MARCHES : Airbus, Veolia, Volkswagen, Nokia, Delivery Hero, Sika, Pandora, H..
11/01Merck & Co.'s COVID-19 Drug Expected To Work Against Omicron, Other Variants
11/01Gilead, Merck & Co. to Evaluate Lung Cancer Combo Therapy in Two Clinical Studies
11/01Merck & Co.'s Keytruda Improves Disease-Free Survival as Adjuvant Therapy for Lung Canc..
10/01Merck Provides Earnings Guidance for the Year 2022 and 2025
10/01MERCK CEO EXPECTS TO DELIVER ADDITIO : Cnbc
10/01Gilead Sciences, Merck To Study Trodelvy, Keytruda Combination For Treatment of Lung Ca..
10/01Neoleukin Therapeutics Collaborating With Merck to Test NL-201, Keytruda Combo in Solid..
10/01Merck to Hold Fourth-Quarter and Full-Year 2021 Sales and Earnings Conference Call on F..
10/01Merck's KEYTRUDA® (pembrolizumab) Showed Statistically Significant Improvement in Disea..
10/01Merck’S Keytruda® Showed Statistically Significant Improvement in Disease-Free Sur..
10/01Merck & Co. Signs Research Deal With US-Based Absci
10/01Italy To Purchase Pfizer, Merck & Co.'s COVID-19 Pills
07/01Merck to Hold Fourth-Quarter and Full-Year 2021 Sales and Earnings Conference Call on F..
07/01Canada Decision on Oral Covid-19 Drugs Likely Weeks Away
07/01MERCK : accord de recherche avec Absci dans l'IA
07/01Health Care Stocks Retreat Premarket Friday
07/01Health Care
07/01Absci Shares Leap Premarket on Collaboration With Merck
07/01Absci Enters Research Collaboration With Merck; Shares Jump
06/01Noxxon provides update on evaluation of nox-a12 in non- oncology indication by a leadin..
06/01Imv announces finalization of the basket clinical study in collaboration with merck and..
06/01Thinking about trading options or stock in Dicks Sporting Goods, Laredo Petroleum, Bank..
06/01Le Nasdaq digère mal la galette
05/01Ireland To Buy COVID-19 Antiviral Drugs From Merck & Co., Pfizer, GSK
05/01Organon, Samsung Bioepis' Biologics License Application for Humira Biosimilar Accepted ..
04/01Merck to Present at the 40th Annual J.P. Morgan Healthcare Conference
04/01L'administration Biden double ses achats de la pilule anti-Covid de Pfizer
04/01Vaccinex Reports Positive Interim Data From Study of Pepinemab, Keytruda Combination to..
04/01Vaccinex Reports Phase Ib KEYNOTE B84 Combination Study of Keytruda® and Pepinemab in P..
04/01MARKETSCREENER’S WORLD PRESS REVIEW : January 4, 2022
04/01PLANÈTE BOURSE : La revue de presse du mardi 4 janvier 2022
04/01Why 2022 Could Open Gangbusters for Covid Stocks (AZN, OTLC, NVAX, PFE, MRNA, MRK, JNJ,..
03/01Health Care Stocks Finishing Lower in Monday Trading
03/01Top Midday Gainers
03/01Health Care Stocks Declining This Afternoon
03/01FDA Grants Fast-Track Designation for Combining Genprex Therapy With Merck's Keytruda a..
03/01Belgium Reportedly to Buy Pfizer, Merck COVID-19 Pills
03/01Belgium To Procure Pfizer, Merck & Co.'s COVID-19 Pills
20212021 BY THE NUMBERS : Big Year For Oil, Precious Metals Slump Despite Rising Inflation, an..
2021CORONA-BLOG/Pfizer-Pille zur Covid-Behandlung auch in Großbritannien zugelassen
2021Consumer Stocks Steady Pre-Bell Thursday
2021Walmart to Dispense Merck, Pfizer COVID-19 Pills at Select Stores
2021Walmart, Sam's Club Pharmacies to Distribute Limited Supply of COVID-19 Antiviral Presc..
2021Dr. Reddy's Laboratories receives DCGI approval to launch Molnupiravir capsules 200mg (..
2021MERCK : L'Inde autorise le Molnupiravir
2021PLANÈTE BOURSE : La revue de presse du mercredi 29 décembre 2021
2021INDIEN : Notzulassung für Corona-Pille und zwei neue Impfstoffe
2021India Approves Merck's COVID-19 Pill Molnupiravir, Two Vaccines for Emergency Use
2021EN DIRECT DES MARCHES : BNP Paribas, Elis, Albioma, Merck, Pfizer, Moderna, Roche...
2021Les investisseurs ont encore faim !
2021India Panel Recommends Covovax, Corbevax and Merck's Covid-19 Pill for Emergency Use, E..
2021Merck & Co.'s COVID-19 Pill Recommended For Emergency Use In India
2021MERCK : un soin du cancer de l'endomètre approuvé au Japon
2021Merck and Eisai Win Japanese Approval of Keytruda Plus Lenvima to Treat Endometrial Ca..
2021KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Approved in Japan for Patients Wit..
2021Japanese Ministry of Health, Labour and Welfare Approves the Combination of Keytruda, M..
2021EN DIRECT DES MARCHES : Orange, Merck, Pfizer, Daimler, Roche, Enel, Crédit Suisse ...
2021Dernière ligne droite avant 2022
2021Merck & Co.'s COVID-19 Pill Granted Approval in Japan
1  2  3  4  5  6  7  8  9  10Siguiente
Próximo evento sobre MERCK & CO., INC.
03/02/22
Próximos eventos en el sector